Newsletter Subscribe

Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Merck & Co Nears $1.3 Billion Acquisition of Eyebiotech

Merck & Co, a global pharmaceutical giant, has finalized a monumental deal worth $3 billion to acquire EyeBio, a leading developer of eye-focused drugs. The agreement includes an upfront payment of $1.3 billion in cash, along with an additional $1.7 billion…

USC Roski Eye Institute Investigates Promising Drugs for TED

The USC Roski Eye Institute is making significant strides in the realm of Thyroid Eye Disease (TED) treatment through pioneering clinical trials exploring new medications. TED, a condition characterized by bulging eyes and potential vision impairment, has traditionally necessitated multiple…

Tips for Choosing the Right Artificial Tears

Dry eyes can be an irritating and persistent problem for many individuals, leading to discomfort and potential vision issues if left untreated. Artificial tears are a common and effective solution for relieving dry eye symptoms. Dry eye is a common…

European Authorization Granted for Lytenava in Wet AMD

Outlook Therapeutics has achieved a significant milestone with the European Commission granting Marketing Authorization for Lytenava (bevacizumab gamma), an innovative ophthalmic formulation designed for the treatment of wet AMD (Age-related Macular Degeneration). This approval marks a pivotal moment as Lytenava…

Opthea Completes Enrollment in Wet AMD Phase 3 Trials

Opthea Limited announced the completion of enrollment in both the COAST and ShORe trials, constituting its pivotal Phase 3 clinical program. This program is designed to assess the safety and superior efficacy of sozinibercept in combination with standard-of-care anti-VEGF-A therapies…

Exonate Adds Dr. Rafiq Hasan to Leadership Team

Exonate announced the expansion of its Board with the appointment of Dr. Rafiq Hasan as Non-Executive Director. This strategic move aims to bolster the company’s expertise in ophthalmology, particularly within the diabetic eye disease sector, as it advances its lead…

Exclusive Interview with Prof. Dr. Oliver Findl

*If you are interested in becoming a part of our OBN Spotlight TV series, reach us at info@ophthalmologybreakingnews.com. Q1: As you reflect on the recent ESCRS 2023 Congress, could you share with us the key highlights and breakthroughs in cataract…

Neuron Discovery Guides Retinal Blood Vessel Formation

Scientists at UC San Francisco have identified a novel type of neuron that plays a crucial role in guiding the formation of the intricate lattice of blood vessels in the retina. This lattice is essential for nourishing the cells responsible…

Pegcetacoplan’s Role in Retinal Atrophy Treatment

Researchers from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and University College London Institute of Ophthalmology, London have conducted a post hoc analysis of data from two phase 3 clinical trials of pegcetacoplan (Syfovre,…

Stay informed and not overwhelmed, subscribe now!